TWI431273B - 生物感測器用之異常輸出偵測系統 - Google Patents
生物感測器用之異常輸出偵測系統 Download PDFInfo
- Publication number
- TWI431273B TWI431273B TW096116094A TW96116094A TWI431273B TW I431273 B TWI431273 B TW I431273B TW 096116094 A TW096116094 A TW 096116094A TW 96116094 A TW96116094 A TW 96116094A TW I431273 B TWI431273 B TW I431273B
- Authority
- TW
- Taiwan
- Prior art keywords
- pulse
- polling
- input signal
- output signal
- biosensor
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title claims description 35
- 238000001514 detection method Methods 0.000 title description 29
- 239000012491 analyte Substances 0.000 claims description 76
- 238000005259 measurement Methods 0.000 claims description 61
- 239000013060 biological fluid Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 36
- 238000003556 assay Methods 0.000 claims description 35
- 229910052760 oxygen Inorganic materials 0.000 claims description 29
- 239000001301 oxygen Substances 0.000 claims description 29
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 17
- 238000004082 amperometric method Methods 0.000 claims description 5
- 238000007619 statistical method Methods 0.000 claims description 3
- 230000007704 transition Effects 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 96
- 238000004458 analytical method Methods 0.000 description 32
- 230000003287 optical effect Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 13
- 239000004020 conductor Substances 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 206010000117 Abnormal behaviour Diseases 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007812 electrochemical assay Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/10—Analysis or design of chemical reactions, syntheses or processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Emergency Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74677106P | 2006-05-08 | 2006-05-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200804805A TW200804805A (en) | 2008-01-16 |
| TWI431273B true TWI431273B (zh) | 2014-03-21 |
Family
ID=38543641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096116094A TWI431273B (zh) | 2006-05-08 | 2007-05-07 | 生物感測器用之異常輸出偵測系統 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8234076B2 (OSRAM) |
| EP (1) | EP2020909A2 (OSRAM) |
| JP (2) | JP5121822B2 (OSRAM) |
| CN (1) | CN101437443B (OSRAM) |
| BR (1) | BRPI0711433A2 (OSRAM) |
| CA (1) | CA2650880C (OSRAM) |
| MX (1) | MX2008014250A (OSRAM) |
| NO (1) | NO20084960L (OSRAM) |
| RU (1) | RU2465812C2 (OSRAM) |
| TW (1) | TWI431273B (OSRAM) |
| WO (1) | WO2007133985A2 (OSRAM) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3172559B2 (ja) | 1991-11-20 | 2001-06-04 | 株式会社クラレ | 艶消しフィルム |
| CA2553632A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
| US8529751B2 (en) | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
| US7966859B2 (en) | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| EP2020909A2 (en) * | 2006-05-08 | 2009-02-11 | Bayer HealthCare LLC | Abnormal output detection system for a biosensor |
| EP2029707A2 (en) | 2006-05-08 | 2009-03-04 | The Lubrizol Corporation | Lubricating composition containing a polymer and antiwear agents |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| EP2222867B1 (en) * | 2007-12-10 | 2018-07-11 | Ascensia Diabetes Care Holdings AG | Rapid-read gated amperometry |
| CA2708038A1 (en) * | 2007-12-10 | 2009-09-03 | Bayer Healthcare Llc | Slope-based compensation |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| US8603768B2 (en) * | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| EP2373984B1 (en) * | 2008-12-08 | 2022-11-30 | Ascensia Diabetes Care Holdings AG | Biosensor signal adjustment |
| DE102009048811B4 (de) * | 2009-10-08 | 2013-07-18 | Eads Deutschland Gmbh | Biosensorvorrichtung mit Selbsttesteinrichtung |
| KR101929057B1 (ko) * | 2010-03-22 | 2018-12-13 | 바이엘 헬쓰케어 엘엘씨 | 바이오센서를 위한 잔여 보상 |
| CA3047242A1 (en) | 2010-06-07 | 2011-12-15 | Ascensia Diabetes Care Holdings Ag | Underfill management system for a biosensor |
| CA2798938C (en) | 2010-06-07 | 2018-08-07 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
| US8923918B2 (en) * | 2010-12-18 | 2014-12-30 | Kallows Engineering India Pvt. Ltd. | Biosensor interface apparatus for a mobile communication device |
| US9008744B2 (en) | 2011-05-06 | 2015-04-14 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
| US9775806B2 (en) | 2011-09-21 | 2017-10-03 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals |
| US9810688B2 (en) * | 2013-03-15 | 2017-11-07 | Robert Bosch Gmbh | Smart glass slide for microarrays |
| US9080196B2 (en) | 2012-09-28 | 2015-07-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9005426B2 (en) | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9958410B2 (en) * | 2013-03-14 | 2018-05-01 | Ascensia Diabetes Care Holdings Ag | Normalized calibration of analyte concentration determinations |
| JP6356707B2 (ja) * | 2013-03-15 | 2018-07-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 電気化学的測定中に高抗酸化物質レベルを検出してそれから分析物濃度をフェイルセイフする方法並びにそれを組み込んだデバイス、装置、及びシステム |
| EP2972268B1 (en) * | 2013-03-15 | 2017-05-24 | Roche Diabetes Care GmbH | Methods of failsafing electrochemical measurements of an analyte as well as devices, apparatuses and systems incorporating the same |
| CN104122882A (zh) * | 2013-04-24 | 2014-10-29 | 中烟机械技术中心有限责任公司 | 巴鲁夫自诊断型传感器的故障诊断系统 |
| CN105445341B (zh) * | 2014-09-12 | 2018-10-16 | 达尔生技股份有限公司 | 电化学的检测试片异常的检测方法 |
| TWI567387B (zh) * | 2014-09-12 | 2017-01-21 | 達爾生技股份有限公司 | 電化學的感測試片本身性質之異常的檢測方法 |
| CN108603853B (zh) * | 2016-02-10 | 2022-08-09 | 索尼公司 | 电特性测量用样本、电特性测量装置和电特性测量方法 |
| CN110249219B (zh) * | 2016-12-05 | 2022-08-23 | 安晟信医疗科技控股公司 | 风险因素监测 |
| KR102031340B1 (ko) * | 2018-03-14 | 2019-10-11 | 주식회사 필로시스 | 혈당 측정 장치, 방법, 및 시스템 |
| US11382541B2 (en) | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
| KR102532761B1 (ko) * | 2019-08-02 | 2023-05-16 | 바이오나임 코포레이션 | 마이크로 바이오센서의 측정 간섭 감소 방법 |
| TWI870545B (zh) * | 2020-02-21 | 2025-01-21 | 美商半導體組件工業公司 | 用於測量工作電極電流之方法、雙向恆電位器、及電池測量系統 |
| CN111681713B (zh) * | 2020-06-10 | 2023-03-31 | 重庆邮电大学 | 一种包含退相干作用的聚合物分子电学性质的模型构建方法及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| US5243516A (en) * | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) * | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| EP0958495B1 (en) | 1997-02-06 | 2002-11-13 | Therasense, Inc. | Small volume in vitro analyte sensor |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| AU3849799A (en) * | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| JP4321966B2 (ja) * | 1998-11-02 | 2009-08-26 | アルザ・コーポレーション | 適合性抗微生物剤を含有する電気輸送式デバイス |
| CA2305922C (en) | 1999-08-02 | 2005-09-20 | Bayer Corporation | Improved electrochemical sensor design |
| GB0005564D0 (en) * | 2000-03-08 | 2000-05-03 | Inverness Medical Ltd | Measurjement of substances in liquid |
| ATE507766T1 (de) * | 2002-03-22 | 2011-05-15 | Animas Technologies Llc | Leistungsverbesserung einer analytenüberwachungsvorrichtung |
| US20040222965A1 (en) * | 2003-05-05 | 2004-11-11 | Riccomini Roy J. | System and method for generating an analog signal in a hand-held computing device |
| US7488601B2 (en) * | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| WO2005114163A1 (en) | 2004-05-14 | 2005-12-01 | Bayer Healthcare Llc | Methods for performing hematocrit adjustment in glucose assays and devices for same |
| EP1913374B1 (en) | 2005-07-20 | 2019-01-09 | Ascensia Diabetes Care Holdings AG | Method for signalling the user to add additional sample to a test strip, method for measuring the temperature of a sample and methods for determining the concentration of an analyte based on gated amperometry |
| EP3483598B1 (en) | 2005-09-30 | 2024-11-06 | Ascensia Diabetes Care Holdings AG | Gated voltammetry |
| EP2020909A2 (en) * | 2006-05-08 | 2009-02-11 | Bayer HealthCare LLC | Abnormal output detection system for a biosensor |
-
2007
- 2007-05-07 EP EP07783344A patent/EP2020909A2/en not_active Ceased
- 2007-05-07 CA CA2650880A patent/CA2650880C/en not_active Expired - Fee Related
- 2007-05-07 CN CN2007800162447A patent/CN101437443B/zh active Active
- 2007-05-07 JP JP2009510115A patent/JP5121822B2/ja active Active
- 2007-05-07 RU RU2008148133/14A patent/RU2465812C2/ru active
- 2007-05-07 BR BRPI0711433-8A patent/BRPI0711433A2/pt not_active IP Right Cessation
- 2007-05-07 WO PCT/US2007/068320 patent/WO2007133985A2/en not_active Ceased
- 2007-05-07 TW TW096116094A patent/TWI431273B/zh not_active IP Right Cessation
- 2007-05-07 MX MX2008014250A patent/MX2008014250A/es active IP Right Grant
-
2008
- 2008-10-17 US US12/253,440 patent/US8234076B2/en active Active
- 2008-11-26 NO NO20084960A patent/NO20084960L/no not_active Application Discontinuation
-
2012
- 2012-06-28 US US13/536,310 patent/US9301717B2/en active Active
- 2012-08-21 JP JP2012182103A patent/JP5373948B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1132643A1 (en) | 2010-03-05 |
| CA2650880A1 (en) | 2007-11-22 |
| US8234076B2 (en) | 2012-07-31 |
| US9301717B2 (en) | 2016-04-05 |
| US20090099787A1 (en) | 2009-04-16 |
| JP2012255803A (ja) | 2012-12-27 |
| CN101437443B (zh) | 2011-11-30 |
| RU2465812C2 (ru) | 2012-11-10 |
| BRPI0711433A2 (pt) | 2011-11-16 |
| US20120271559A1 (en) | 2012-10-25 |
| JP5121822B2 (ja) | 2013-01-16 |
| CA2650880C (en) | 2015-11-24 |
| JP2009536744A (ja) | 2009-10-15 |
| JP5373948B2 (ja) | 2013-12-18 |
| CN101437443A (zh) | 2009-05-20 |
| NO20084960L (no) | 2008-11-26 |
| TW200804805A (en) | 2008-01-16 |
| RU2008148133A (ru) | 2010-06-20 |
| WO2007133985A3 (en) | 2008-01-10 |
| MX2008014250A (es) | 2008-11-26 |
| EP2020909A2 (en) | 2009-02-11 |
| WO2007133985A2 (en) | 2007-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI431273B (zh) | 生物感測器用之異常輸出偵測系統 | |
| JP6448504B2 (ja) | 勾配ベース補正 | |
| TWI449905B (zh) | 用於生物感測器之未足量偵測系統 | |
| US10724985B2 (en) | Biosensor for determining a concentration of a biosensor using an underfill procedure | |
| JP2011506966A5 (OSRAM) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |